Loading stock data…
PACS
$33.83+1.24 (+3.80%)
Pre-Market$33.50-0.33 (-0.98%)· Last close May 6
PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
PACS Group, Inc. in the Healthcare sector is trading at $33.83. The stock is currently 21% below its 52-week high of $43.08, remaining 33.4% above its 200-day moving average. Technical signals show neutral RSI of 47 and bearish MACD signal, explaining why PACS maintains its current momentum and trend strength. The Whystock Score of 75/100 reflects a high-conviction bullish alignment.
Ecosystem Influences
Neutral momentum (RSI 47) — price action in range
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$33.83
Potential Downside
21%
Whystock Fair Value$26.73
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. It also provides senior care and independent living facilities. The company engages in the acquisition, ownership, an...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$5.35B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
27.90
Beta
Defensive asset. Lower volatility than the S&P 500.
0.06
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
20.23%
Volume
Today's trading volume
386,672
Recent News
PACS Group (PACS) Appoints Carey P. Hendrickson as Chief Financial Officer
PACS Group Inc. (NYSE:PACS) is one of the best up and coming stocks with highest upside potential. On April 27, PACS Group appointed Carey P. Hendrickson as its Chief Financial Officer. Hendrickson, a seasoned financial leader with nearly 40 years of experience, succeeds co-founder Mark Hancock, who had served as interim CFO since September 2025. […]
Is It Too Late To Consider PACS Group (PACS) After Its 266.3% One-Year Surge?
Wondering whether PACS Group is still interesting at around US$35.27, or if the big gains are already behind it, starts with a clear view of what you are paying for today. The stock has returned 15.3% over the last 30 days, sits 10.7% lower year to date, and is up 266.3% over the past year. This naturally raises questions about how much is already priced in and how risk has shifted. Recent attention around PACS Group has focused on its role in the healthcare space and how investors are...
Wall Street Analysts Think PACS Group, Inc. (PACS) Could Surge 30.96%: Read This Before Placing a Bet
The average of price targets set by Wall Street analysts indicates a potential upside of 31% in PACS Group, Inc. (PACS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
PACS or MEDP: Which Is the Better Value Stock Right Now?
PACS vs. MEDP: Which Stock Is the Better Value Option?
New Strong Buy Stocks for April 14th
SHEL, XYZ, UAA, PACS and LAUR have been added to the Zacks Rank #1 (Strong Buy) List on April 14, 2026.